130
Views
1
CrossRef citations to date
0
Altmetric
General Medicine

Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study

ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 4819-4834 | Received 28 Jul 2023, Accepted 13 Oct 2023, Published online: 26 Oct 2023

References

  • Deane KD, Holers VM. The natural history of rheumatoid arthritis. Clin Ther. 2019;41(7):1256–1269. doi:10.1016/j.clinthera
  • Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–196. doi:10.1016/j.immuni
  • Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Jt Bone Spine. 2013;80(1):29–33. doi:10.1016/j.jbspin.2012.02.005
  • Lee Y, Ahn GY, Lee J, et al. Excess mortality persists in patients with rheumatoid arthritis. Int J Rheum Dis. 2021;24(3):364–372. doi:10.1111/1756-185X.14058
  • Videm V, Houge IS, Liff MH, Hoff M. Inflammation mediates approximately one quarter of excess relative all-cause mortality in persons with rheumatoid arthritis: the Trøndelag Health Study. Sci Rep. 2022;12(1):18599. doi:10.1038/s41598-022-21977-9
  • Ometto F, Fedeli U, Schievano E, Botsios C, Punzi L, Corti MC. Cause-specific mortality in a large population-based cohort of patients with rheumatoid arthritis in Italy. Clin Exp Rheumatol. 2018;36(4):636–642.
  • Scott DL, Coulton BL, Symmons DPM, Popert AJ. Long-term outcome of treating rheumatoid arthritis: results aft er 20 years. Lancet. 1987;329(8542):1108–1111. doi:10.1016/S0140-6736(87)91672-2
  • Shen Q, Du Y. A comprehensive review of advanced drug delivery systems for the treatment of rheumatoid arthritis. Int J Pharm. 2023;635:122698. doi:10.1016/j.ijpharm.2023.122698
  • Feng X, Chen Y. Drug delivery targets and systems for targeted treatment of rheumatoid arthritis. J Drug Target. 2018;26(10):845–857. doi:10.1080/1061186X.2018.1433680
  • Fang Y, Liu J, Xin L, et al. Traditional Chinese medicine compound preparations are Associated with low disease-related complication rates in patients with rheumatoid arthritis: a retrospective cohort study of 11,074 patients. BioMed Res Int. 2023;2023:1019290. doi:10.1155/2023/1019290
  • Gu XH, Chen P, Zhu L, et al. Efficacy observation of juanbi decoction adjuvant therapy for active stage rheumatoid arthritis. Chin J Integr Tradit West Med. 2021;41(7):812–816.
  • Dong WZ, Liu J, Ling X, Fang YY, Wen JT. Data mining research on different formulations of tripterygium wilfordii ameliorating immune inflammation in patients with rheumatoid arthritis. J IMMUNOL. 2018;34(10):894–899+905. doi:10.13431/j.cnki.immunol.j.20180138
  • Huang D, Liu J, Wan L, Jiang H, Sun Y, Long Y. Study on treating “Bi” from spleen. J Rheum Arthritis. 2021;10(1):46–50.
  • Zhou W, Wang Y, Huang Y, et al. Huangqin qingre qubi capsule inhibits RA pathology by binding FZD8 and further inhibiting the activity of Wnt/β-catenin signaling pathway. J Ethnopharmacol. 2023;302:115886. doi:10.1016/j.jep.2022.115886
  • Liu JQ, Liu XC, Liu J, Zhang YY, Wang TJ, Zhou A. HPLC fingerprint of huangqin qingre chubi capsule preliminary study and determination of three components. Chin Med Biotechnol. 2022;17(1):56–58.
  • Dong XT, Gan PR, Ke JT, et al. Simultaneous determination of six active components in huangqin qingre chure chubi capsule by ultra-high-performance liquid chromatography-tandem mass spectrometry. J Anhui Univ Chinese Med. 2021;40(6):97–102.
  • Ge P, Zhang H, Sun XC, et al. Effect of huangqin qingre chubi capsule on serum IL-1β and IL-6 of adjuvant arthritis rats. Trad Chin Drug Res Clin Pharmacol. 2014;25(1):8–10. doi:10.3969/j.issn.1003-9783.2014.01.003
  • Jiang Y, Zhang J, Meng M, et al. Experimental study of huangqin qingre chubi capsule on anti-inflammatory action of adjuvant arthritis in rats. West China Med J. 2015;30(2):178–180.
  • Wang X, Chang J, Zhou G, et al. The traditional Chinese medicine compound huangqin qingre chubi capsule inhibits the pathogenesis of rheumatoid arthritis through the CUL4B/Wnt pathway. Front Pharmacol. 2021;12:750233. doi:10.3389/fphar.2021.750233
  • Guo JC, Liu J, Zhang XJ, Zhou Q, Huang D, Song Q. Effect of huangqin qingre chubi capsules containing serum on oxidative stress and protein expression of AMPK and FoxO3a in rheumatoid arthritis patients. China J Chin Mater Med. 2020;45(13):3228–3232. doi:10.19540/j.cnki.cjcmm.20200427.502
  • Ding BJ, Huang CB, Fu P, Chen LL. Clinical observation on 30 cases of rheumatoid arthritis with damp-heat bi-obstructing syndrome treated by Huangqin Qingre Chubi Jiaonang combined with shire bizu waixi fang. J Gansu Univ Chin Med. 2022;39(4):53–57. doi:10.16841/j.issn1003-8450.2022.04.09
  • Cao YH, Liu J. Clinical efficacy of heat-clearing and diuresis-promoting prescription combined with western medicine treatment for damp-heat rheumatoid arthritis. J Anhui Univ Chinese Med. 2014;33(6):19–22.
  • Cheng LL, Huang CB, Fu P, Ding BJ. Clinical observation of huangqin qingre chubi capsule combined with celecoxib in the treatment of knee osteoarthritis. Clin J Trad Chin Med. 2021;33(7):1375–1378. doi:10.16448/j.cjtcm.2021.0739
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–1588. doi:10.1136/ard.2010.138461
  • Jiang Q, Wang HL, Gong X, Luo CG. The diagnosis and treatment guidelines of rheumatoid arthritis combined with disease and pattern. J Tradit Chin Med. 2018;59(20):1794–1800. doi:10.13288/j.11-2166/r.2018.20.018
  • Wen JT, Liu J, Wan L, Xin L, Dong WZ, Fang YY. Outcome events of 1468 patients with rheumatoid arthritis: a cohort study. J Anhui Univ Chinese Med. 2017;36(5):13–17.
  • Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002;359(9302):248–252. doi:10.1016/S0140-6736(02)07451-2
  • Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi:10.1093/biomet/70.1.41
  • Wan XH, Lu XF. Diagnostics. 9th ed. Beijing: People’s Medical Publishing House; 2018.
  • Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–164. doi:10.1136/bmj.305.6846.160
  • Han M, Liu HX, Tang XP, et al. Expert consensus on clinical outcome scales reported by patients with rheumatoid arthritis in China. J Tradit Chin Med. 2018;59(10):897–900. doi:10.13288/j.11-2166/r.2018.10.020
  • Davies AR, Ware JE. Measuring Health Perceptions in the Health Insurance Experiment. Santa Monica, CA: Rand Corporation; 1981.
  • Burckhardt SC, Jones DK. Adult measures of pain: the McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven‐Yale Multidisciplinary Pain Inventory (WHYMPI)[J]. Arthritis Care Res. 2003;49(S5). doi:10.1002/art.11440
  • Zung WWK. A self-rating depression scale. Arch Gen Psychiatry. 1965;12(1):63. doi:10.1001/archpsyc.1965.01720310065008
  • Goyer PF, Brown GL, Minichiello MD, Major LF. Mood-altering effects of disulfiram in alcoholics. J Stud Alcohol. 1984;45(3):209–213. doi:10.15288/jsa.1984.45.209
  • Zheng XY. Guiding Principles for Clinical Research of New Traditional Chinese Medicine. Beijing: China Medical Science and Technology Press; 2002.
  • Ranstam J, Cook JA, Ranstam J, Cook JA. Kaplan–Meier curve. Br J Surg. 2017;104(4):442. doi:10.1002/bjs.10238
  • The xiantao academic. Available from: https://www.xiantaozi.com/products/apply/1150d1f4-ccad-4cec-a19d-7826235c52e5/analyse/2057dbc9-c8aa-4b3f-88c8-206cf336bb68. Accessed 27, January 2023.
  • Fisher LD, Lin DY. Time-dependent covariates in the cox proportional-hazards regression model. Annu Rev Public Health. 1999;20(1):145–157. doi:10.1146/annurev.publhealth.20.1.145
  • Austin PC, Goel V, Van Walraven C. An introduction to multilevel regression models. Can J Public Health. 2001;92(2):150–154. doi:10.1007/BF03404950
  • Han J, Pei J, Kamber M. Data Mining: Concepts and Techniques. 3th ed. Amsterdam: Morgan Kaufmann Publishers; 2011.
  • Huang D, Liu J, Xin L, et al. Data mining study on prescription patterns of different dosage forms of Chinese herbal medicines for treating and improving immune-inflammatory indices in patients with rheumatoid arthritis. Chin J Integr Med. 2022;28(3):215–222. doi:10.1007/s11655-020-3480-1
  • Fang Y, Liu J, Xin L, et al. Identifying compound effect of drugs on rheumatoid arthritis treatment based on the association rule and a random walking-based model. BioMed Res Int. 2020;2020:1–10. doi:10.1155/2020/4031015
  • Liu GJ, Wu T. Clinical implemation of forest plots in meta-analysis. Clin Implem Forest Plots Meta Anal. 2004;4(3):198–201.
  • Costello R, David T, Jani M. Impact of adverse events associated with medications in the treatment and prevention of rheumatoid arthritis. Clin Ther. 2019;41(7):1376–1396. doi:10.1016/j.clinthera.2019.04.030
  • Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2009;68(7):1100–1104. doi:10.1136/ard.2008.093690
  • Jayachandran M, Koshy V, David R, et al. Adverse reaction profile of sulfasalazine and its persistence in chronic therapy of rheumatoid arthritis and spondyloarthritis: a multicentric observational study. Int J Clin Pharmacol Ther. 2022;60(08):327–335. doi:10.5414/CP204120
  • Askling J, Dixon W. The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Curr Opin Rheumatol. 2008;2(20):138–144. doi:10.1097/BOR.0b013e3282f4b392
  • George MD, Baker JF, Winthrop K, et al. Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis: a cohort study. Ann Intern Med. 2020;173(11):870–878. doi:10.7326/M20-1594
  • Xue CC, Zhang AL, Lin V, Myers R, Polus B, Story DF. Acupuncture, chiropractic and osteopathy use in Australia: a national population survey. BMC Public Health. 2008;8(1):105. doi:10.1186/1471-2458-8-105
  • Yang L, Adams J. The role of traditional Chinese medicine in arthritis management: why we need public health and health services research. Front Public Health. 2020;8:597917. doi:10.3389/fpubh.2020.597917
  • Yang L, Sibbritt D. Factors associated with Chinese herbal medicine use among middle-aged and older women with arthritis: evidence from China. Sci Rep. 2022;12(1):12566. doi:10.1038/s41598-022-16927-4
  • Wang YR, Liu L, Wang XY, et al. The efficacy of the traditional Chinese medicine Jia Wei Niu Bang Zi granule combined with methotrexate in treating active rheumatoid arthritis: a multicenter, randomized, double-blinded controlled clinical trial. Medicine. 2019;98(6):14424. doi:10.1097/MD.0000000000014424
  • Xing Q, Fu L, Yu Z, Zhou X. Efficacy and safety of integrated traditional Chinese medicine and western medicine on the treatment of rheumatoid arthritis: a meta-analysis. Evid Based Complement Alternat Med. 2020;2020:1–15. doi:10.1155/2020/4348709
  • Fang J, Liu M, Huang Z, et al. Efficacy and safety of TCMs with anti-inflammatory effect in patients with rheumatoid arthritis: a network meta-analysis. Front Immunol. 2023;14:1114930. doi:10.3389/fimmu.2023.1114930
  • Fan HX, Liu J, Huang CB, et al. Clinical effects of huangqin qingre chubi capsules combined with western medicine in the treatment of acute gouty arthritis. WJTCM. 2021;16(17):2600–2604+2610.
  • Huang D, Liu J, Wan L, Song Q, Guo JC, Zhou Q. Effects of huangqin qingre chubi capsule on efficacy and oxidative stress of ankylosing spondylitis. Chin J Immunol. 2019;35(12):1448–1452.
  • Sun Y, Liu J, Xin L, et al. Traditional Chinese medicine is associated with reduced risk of readmission in rheumatoid arthritis patients with anemia: a retrospective cohort study. Evid Based Complement Alternat Med. 2022;2022:1–10. doi:10.1155/2022/4553985
  • Wang J, Liu J, Wen JT, et al. Effect of xinfeng capsule combined with huangqin qingre chubi capsule on rheumatic arthritis association rules analysis of self-perception of patient. Chin J Clin Health. 2021;24(5):639–645.
  • Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration: assessment of RA incidence in Sweden. Arthritis Care Res. 2013;65(6):870–878. doi:10.1002/acr.21900
  • Intriago M, Maldonado G, Cárdenas J, Ríos C. Clinical characteristics in patients with rheumatoid arthritis: differences between genders. Sci World J. 2019;2019:1–6. doi:10.1155/2019/8103812c
  • Guo JC, Liu J, Xin L, Huang D, Zhou Q, Song Q. Effects of furong ointment external application combined with Chinese medicine oral administration on immune inflammation in rheumatoid arthritis patients explored by HIS data analysis. J IMMUNOL. 2018;34(3):230–238. doi:10.13431/j.cnki.immunol.j.20180035
  • Guo JC, Liu J, Xin L, Huang D, Zhou Q, Song Q. Evaluation of effect of hibiscus paste external application combined with traditional Chinese medicine on inflammatory indices of patients with active rheumatoid arthritis based on random walk model. Chin J Immunol. 2018;34(6):854–860.
  • Deniz O, Cavusoglu C, Satis H, et al. Sleep quality and its associations with disease activity and quality of life in older patients with rheumatoid arthritis. Eur Geriatr Med. 2023;14(2):317–324. doi:10.1007/s41999-022-00739-w
  • Hsieh SC, Tsai PH, Kuo CF, et al. Health-related quality of life improvement by Adalimumab therapy in patients with rheumatoid arthritis in Taiwan: a nationwide prospective study. J Chin Med Assoc. 2023;86(4):366–374. doi:10.1097/JCMA.0000000000000889
  • Matcham F, Scott IC, Rayner L, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(2):123–130. doi:10.1016/j.semarthrit.2014.05.001
  • Qian J, Li M, Zhang X, et al. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J. 2019;53(2):1800081. doi:10.1183/13993003.00081-2018
  • Zhang C, Wu X, Yuan Y, et al. Effect of solution-focused approach on anxiety and depression in patients with rheumatoid arthritis: a quasi-experimental study. Front Psychol. 2022;13:939586. doi:10.3389/fpsyg.2022.939586
  • Yoshii I, Sawada N, Chijiwa T. Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis. Clin Rheumatol. 2023;42(4):1027–1038. doi:10.1007/s10067-022-06432-4
  • Oude Voshaar MAH, Das Gupta Z, Bijlsma JWJ, et al. International consortium for health outcome measurement set of outcomes that matter to people living with inflammatory arthritis: consensus from an international working group. Arthritis Care Res. 2019;71(12):1556–1565. doi:10.1002/acr.23799
  • Sun Y, Liu J, Fang L, Zhu FB, Tan B, Zhang PH. Study on anxiety and depression of 604 patients with rheumatoid arthritis. J Rheum Arthritis. 2016;5(9):9–15.
  • Zhang Y, Liu J, Huang D, et al. Feeling changes of 135 patients with rheumatoid arthritis and related analyses. J Rheum Arthritis. 2019;8(11):15–19.